Evidence map›Paper›PMID 40278472›Full record

ReviewNanomaterials (Basel, Switzerland)2025

Recent Developments in Automated Reactors for Plasmonic Nanoparticles.

Shan He, Tong Luo, Xiao'e Chen, David James Young, Matt Jellicoe

Abstract readReview
In one paragraph

Review in Nanomaterials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shan HeSchool of Food and Pharmacy, Zhejiang Ocean University, Zhoushan 316022, China.
Tong LuoSchool of Food and Pharmacy, Zhejiang Ocean University, Zhoushan 316022, China.
Xiao'e ChenSchool of Food and Pharmacy, Zhejiang Ocean University, Zhoushan 316022, China.
David James YoungJames Watt School of Engineering, University of Glasgow, Glasgow G12 8QQ, UK.
Matt JellicoeCollege of Medicine and Public Health, Flinders University, Adelaide 5042, Australia.ORCID 0000-0002-9079-5307

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Automated reactors are transforming nanomaterial synthesis by enabling precise, multistep control over morphology and reaction pathways. This review discusses recent advancements in robotic batch and continuous-flow platforms, highlighting their role in expanding chemical space exploration and adaptive manufacturing. Despite progress, challenges remain in integrating automation for complex, multistep syntheses due to the intricate interplay of chemical and physical processes. Emerging process analytical technologies and advanced control software are enhancing real-time monitoring, adaptive feedback loops, and self-optimizing synthesis strategies. We categorize these developments, emphasizing their impact on plasmonic nanomaterial fabrication and outlining future directions for autonomous synthesis.

Indexed as

automated reactorscontinuous flow platformplasmonic nanoparticles

Identifiers

PMID40278472
PMCPMC12029605

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.